BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25376296)

  • 41. Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance.
    Cheung ST; Cheung PF; Cheng CK; Wong NC; Fan ST
    Gastroenterology; 2011 Jan; 140(1):344-55. PubMed ID: 20682318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis.
    Yoo JE; Kim YJ; Rhee H; Kim H; Ahn EY; Choi JS; Roncalli M; Park YN
    PLoS One; 2017; 12(1):e0170465. PubMed ID: 28114366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients.
    Reggiani Bonetti L; Migaldi M; Caredda E; Boninsegna A; Ponz De Leon M; Di Gregorio C; Barresi V; Scannone D; Danese S; Cittadini A; Sgambato A
    Scand J Gastroenterol; 2012 Oct; 47(10):1211-7. PubMed ID: 22856425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
    Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
    Yamashita T; Honda M; Nakamoto Y; Baba M; Nio K; Hara Y; Zeng SS; Hayashi T; Kondo M; Takatori H; Yamashita T; Mizukoshi E; Ikeda H; Zen Y; Takamura H; Wang XW; Kaneko S
    Hepatology; 2013 Apr; 57(4):1484-97. PubMed ID: 23174907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
    Zhang Y; Fan Y; Mei Z
    Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells.
    Wilson GS; Hu Z; Duan W; Tian A; Wang XM; McLeod D; Lam V; George J; Qiao L
    Stem Cells Dev; 2013 Oct; 22(19):2655-64. PubMed ID: 23638793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD133 confers cancer stem-like cell properties by stabilizing EGFR-AKT signaling in hepatocellular carcinoma.
    Jang JW; Song Y; Kim SH; Kim JS; Kim KM; Choi EK; Kim J; Seo HR
    Cancer Lett; 2017 Mar; 389():1-10. PubMed ID: 28034805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma.
    Fujioka M; Nakashima Y; Nakashima O; Kojiro M
    Hepatology; 2001 Dec; 34(6):1128-34. PubMed ID: 11732002
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi.
    Pang YB; Zhong JH; Luo XL; Ou C; Guo Z; Xiang BD; Peng NF; Li LQ
    Tumour Biol; 2016 May; 37(5):5879-84. PubMed ID: 26586401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis.
    Zhong C; Wu JD; Fang MM; Pu LY
    Tumour Biol; 2015 Sep; 36(10):7623-30. PubMed ID: 25921286
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variation of stemness markers expression in tumor nodules from synchronous multi-focal hepatocellular carcinoma - an immunohistochemical study.
    Lo RC; Leung CO; Chok KS; Ng IO
    Diagn Pathol; 2017 Aug; 12(1):56. PubMed ID: 28764740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
    Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biology and clinical implications of CD133(+) liver cancer stem cells.
    Ma S
    Exp Cell Res; 2013 Jan; 319(2):126-32. PubMed ID: 22999864
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High expression of cancer stem cell markers in cholangiolocellular carcinoma.
    Iwahashi S; Utsunomiya T; Shimada M; Saito Y; Morine Y; Imura S; Ikemoto T; Mori H; Hanaoka J; Bando Y
    Surg Today; 2013 Jun; 43(6):654-60. PubMed ID: 23192764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi.
    Yu XH; Xu LB; Liu C; Zhang R; Wang J
    Dig Dis Sci; 2011 Jan; 56(1):252-9. PubMed ID: 20437099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. "Fibrous nests" in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome.
    Désert R; Mebarki S; Desille M; Sicard M; Lavergne E; Renaud S; Bergeat D; Sulpice L; Perret C; Turlin B; Clément B; Musso O
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):195-207. PubMed ID: 27545991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    J Cancer Res Clin Oncol; 2003 Sep; 129(9):531-5. PubMed ID: 12898236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.